Royal DSM has announced that its venture investment arm, DSM Venturing, has mad an equity investment in S-Biomedic NV.
S-Biomedic NV is a Belgium-based skin microbiome company working in the cosmetic sector. The investment completes its latest Series A financing round; it also underline’s DSM’s interest in the skin microbiome. Since its 2001 inception, DSM Venturing has invested in more than 50 emerging companies.
“With its long-established expertise in skin biology and in-depth knowledge in the field of epidermal science DSM is well placed to extend its research and innovation focus on the skin microbiome,” said Rishabh Pande, vice president, marketing and innovation personal care and aroma at DSM. “We have already made encouraging discoveries about how skin actives in our existing product portfolio work on the skin and scalp microbiome. Through this investment, we hope to foster further innovation in the field.”